新型针具治疗肌筋膜痛的研究进展

Research progress of new needles on myofascial pain syndrome

通过对肌筋膜痛的发病机制、诊疗及近年来新型针具治疗肌筋膜痛的相关文献检索、分析和归纳总结后,发现其发病率高,发病机制尚有争议。本病目前临床尚无治本之法,均以对症治疗为主。文献报道新型针具治疗肌筋膜痛疗效明显且具有特色,但其临床治疗缺乏统一规范的操作标准、权威的治疗方案及疗效判定标准,治疗机制缺乏共识。今后应在进一步探索研究其发病机制基础上,制定新型针具统一规范的操作、权威治疗方案及疗效判定标准,同时展开对新型针具治疗肌筋膜痛机制的有关基础研究,以便为其临床应用提供科学依据。

By retrieving, analyzing and summarizing literature related to myofascial pain syndrome（MPS） pathogen- esis, its diagnosis and treatment and new needles therapy for MPS, the article finds out that it presents a high inci- dence but its pathogenesis is still controversial.At present, there is no clinical method to cure the disease and clinical treatment could only alleviate its symptoms.The therapeutic function of new needles for MPS is obvious and charac- teristic according to the relevant documents, but the clinical treatment of MPS with new needles lacks standardized operation standards, authoritative treatment plan and criteria of curative effect.And No consensus on the treatment mechanism of new needles is reached. So standardized operation standards, authoritative treatment plan and criteria of curative effect should be established on the basis of the researches on pathogenesis of MPS.Meanwhile, fundamental researches on mechanism of new needles therapy for MPS should be conducted to provide scientific evidence to clini- cal practices.